Johnson & Johnson: A Safe Hold, But Lacking Catalysts To Beat The Market

Johnson & Johnson's business is in a stable, mature phase, suggesting slow yet steady growth. Click here to read why JNJ stock is a Hold.
Hosted on MSN

Johnson & Johnson's Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income

Johnson & Johnson continues to generate plenty of free cash flow to cover its dividend. The healthcare giant also maintains an elite balance sheet. With more growth ahead, it should have no trouble ...
katc

Johnson & Johnson vaccine: FDA report finds single-shot vaccine to be safe, effective

An FDA report released Wednesday indicates that Johnson & Johnson’s single-shot COVID-19 vaccine is safe and effective, setting the stage for its potential approval and distribution in the coming days ...